UNSPSC 51282418: Carbenicillin sodium

This classification denotes an extended spectrum penicillin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9TS4B3H261. European Medicines Agency schedules Carbenicillin disodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01041MIG. Carbenicillin disodium generally arises in the molecular formula C17H16N2NA2O6S. The term 'carbenicillin disodium' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule carbenicillin sodium under HS 29411090.

SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3CCCCC3)C(=O)[O-])C(=O)[O-])C.[NA+].[NA+].

UNSPSC 51282418 Carbenicillin sodium is a Commodity code for a specific pharmaceutical product, yet the recent state and local opportunities posted under this code do not reflect procurement of carbenicillin sodium itself. Instead, the opportunities signal procurement activity in pharmaceutical supply and emergency medical countermeasures — the Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and Seminole County, Florida released an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually. The code shows activity from state health departments and county health agencies, both of which use cooperative purchasing vehicles and competitive bidding to source pharmaceutical and medical-supply products for public health missions.

Geographic activity centers on Florida and Illinois based on recent postings. The Illinois Department of Public Health contract, awarded in August 2026, represents a multi-year pharmaceutical supply commitment through a state-level cooperative vehicle; Seminole County's IFB, posted in June 2026 with a July 26, 2023 response deadline, targets quarterly delivery of naloxone and drug deactivation systems to support community health initiatives. Neither opportunity directly reflects carbenicillin sodium procurement — the code's nominal scope appears misaligned with the pharmaceutical and emergency-response categories actually being solicited under it. Bidders pursuing this code should verify the precise product requirements in individual RFQs and IFBs, as the posted opportunities suggest state and local agencies are using this code classification for a broader class of pharmaceutical and medical-supply procurement rather than for carbenicillin specifically.